Humoral immune responses to microbial infections in the genital tract.
about
Herpes simplex virus and varicella zoster virus, the house guests who never leaveNovel vaccine development strategies for inducing mucosal immunityA review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infectionA comparative analysis of gene expression patterns and cell phenotypes between cervical and peripheral blood mononuclear cells.Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responsesKinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in miceAntibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design.Mucosal immunity in the female genital tract, HIV/AIDSInnate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.Vaccines against gonorrhea: current status and future challenges.Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunityInfluence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpesProtein-coated nanoparticles are internalized by the epithelial cells of the female reproductive tract and induce systemic and mucosal immune responses.Methods for evaluation of humoral immune responses in human genital tract secretions.Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments.Immunization for protection of the reproductive tract: a review.The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.Molecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections.Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loadsVaginal immunization to elicit primary T-cell activation and dissemination.Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.Immunologic uniqueness of the genital tract: challenge for vaccine development.Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and SubclassesAntiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques.Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis.Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development.Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in miceComparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women.Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responsesFunctional diversity of human vaginal APC subsets in directing T-cell responses.Dendritic cells and vaccine design for sexually-transmitted diseases.Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.Mucosal immunology of HIV infection.Persistence, immune response, and antigenic variation of Mycoplasma genitalium in an experimentally infected pig-tailed macaque (Macaca nemestrina).
P2860
Q21195896-5FF32958-5F48-4924-B7B7-C85247D81261Q24607533-35F8A75B-17D5-4F38-9755-AE486DAE2E73Q26786555-434C84EA-944C-4957-A027-CDC2681D99F0Q33518544-53F43FE2-4BBC-4D77-9FCA-26E5AB12ED5AQ33624872-23DA3DFC-E6BA-4D92-B477-6B66962F9861Q33665816-E02D44F8-B7E7-4979-AA29-9E708EDF7563Q33716593-E13D43FF-B231-4ECB-91D3-AC783EF70CE8Q33883543-8F6DE27D-DF22-4B1E-8FAF-83EB3B7A78B3Q33913898-42E5CA12-A9CE-4561-BABC-083EEE225637Q34275424-7DE3982E-6EBB-457D-89DD-FF706B45FDDFQ34339797-53A05D9A-BFFF-46F3-8B0A-9D0DF1168861Q34369729-22CA8935-6C0B-4D7A-9C3B-1CB8A6F9A271Q34415303-3548CA5B-89ED-4825-86D1-8B23F76444F3Q34429327-491D7F11-30C5-4374-A3B1-092894B80511Q34648207-66A38F94-194C-43B4-B74B-BE9AACAFF176Q34663077-821B0DCF-6B0D-47D1-8915-FBDA9C540083Q34676467-8A13D26B-CE21-4B84-93AC-CB4E4ACBF0DCQ34721358-7FF15DB9-2D7B-418D-9A7A-C5F410BBC433Q34767024-7F96C651-F2CD-4FC6-98D9-54BAAD50D36AQ34943892-B36BDB2B-3F4E-49DF-9C1D-29358F04E520Q34974782-192A64E6-F13D-46DA-AD4E-CBCC19937E45Q35019917-05475DE7-74FF-44A2-9D8B-DFEACF6FEDC3Q35056804-FB146816-DD96-4DE8-8214-26EC3950F6F5Q35069383-89C974E0-00B9-4246-A25D-CB329C523A7BQ35093052-29724E8C-01C8-49E8-8196-151A0FFD0273Q35878788-0F89F081-BF07-4B08-A46E-EC13D7BEEFD1Q36086635-816FF41C-45F7-489A-A988-C8C1F2B36E2EQ36099546-86D49870-FCB7-4DAA-85C7-5786EC019D15Q36118373-1087DE78-7276-4280-A4DB-007703B025B9Q36155560-C50344E4-7125-48CF-A253-C45571742676Q36373913-729AE394-408E-4410-B741-17297C91355FQ36383799-3D506450-F34C-4508-BE28-D94B0425B92BQ36427185-C820440B-1A8B-4824-93E9-2D23882D7072Q36547166-C8C7769A-ABB1-45A7-9AE5-88BC15080FB7Q36571388-5EEF297A-2B1E-4A94-B43E-B873DF3C6154Q36597690-DB819E66-354C-45F3-B371-6BA1A2F1B083Q36681262-605EB71D-CE51-47E3-8C84-E0A643701C53Q36844746-D4E17B8E-1552-48B3-8F35-EC4494FD727BQ36957775-3BDD289B-88A7-49B8-B98E-370E7D6B1A5DQ37036116-46482147-6DDD-4CE0-A730-B6D4317DE825
P2860
Humoral immune responses to microbial infections in the genital tract.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Humoral immune responses to microbial infections in the genital tract.
@ast
Humoral immune responses to microbial infections in the genital tract.
@en
Humoral immune responses to microbial infections in the genital tract.
@nl
type
label
Humoral immune responses to microbial infections in the genital tract.
@ast
Humoral immune responses to microbial infections in the genital tract.
@en
Humoral immune responses to microbial infections in the genital tract.
@nl
prefLabel
Humoral immune responses to microbial infections in the genital tract.
@ast
Humoral immune responses to microbial infections in the genital tract.
@en
Humoral immune responses to microbial infections in the genital tract.
@nl
P1476
Humoral immune responses to microbial infections in the genital tract.
@en
P2093
Jiri Mestecky
Michael W Russell
P304
P356
10.1016/S1286-4579(02)01585-X
P577
2002-05-01T00:00:00Z